Surgery Partners, a leading short-stay surgical facility operator, announced a 4.5% revenue increase to $810.9 million in Q1 2026, driven by a 4.4% rise in same-facility revenues and a slight 0.6% increase in cases. Despite a net loss of $35.9 million, the company posted an Adjusted EBITDA of $102.3 million, close to last year's level. It reaffirmed its 2026 revenue guidance of $3.35 to $3.45 billion and Adjusted EBITDA of at least $530 million, citing strong fundamentals and ongoing cost management. The company remains focused on physician recruitment and portfolio optimization to drive long-term growth and operational excellence.
A three-day online training on Pharmaceutical Regulatory Affairs in Asia is scheduled for October 20-22, 2026, aiming to help professionals understand diverse regulatory requirements across major Asian markets including China, India, Korea, and ASEAN...
The global workwear market, valued at $265.12 billion in 2025, is expected to grow to $344.71 billion by 2031 with a 4.5% CAGR. Growth is fueled by rising corporate employment worldwide, especially in Asia-Pacific, and increased focus on professional...
The global microalgae-based aquafeed market is projected to grow from $320 million in 2026 to $481 million by 2031, at an 8.5% CAGR. Key growth drivers include rapid cost reductions in closed photobioreactor farming, making algae competitive with fis...
The global consumer finance market is projected to expand from $9.87 trillion in 2025 to $14.08 trillion by 2031, growing at a 6.17% CAGR. Key growth drivers include embedded finance at point-of-sale, which boosts credit uptake by integrating lending...
Xcel Brands has signed a licensing agreement with KBL Group to produce ready-to-wear collections for OFF/DUTY by Coco Rocha, a fashion brand created with supermodel Coco Rocha. KBL Group will handle sourcing, product development, manufacturing, and s...
